Greenland Mines Ltd (NasdaqCM: GRML)
Health Care · Biotechnology · US
$5.46
-9.39% today · -80.5% 1Y
Greenland Mines Ltd (NasdaqCM: GRML) operates in the Biotechnology industry within the Health Care sector. The company is valued at $80.35M and employs 5 people.
Over the last twelve months the share price has lost 80.5%, trading between 2.82 and 36.99.
Tweenvest scores Greenland Mines Ltd across four factors: quality 35/100, value 58/100. Its strongest factor is value.
GRML price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $80.35M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -12.36
- Dividend yield
- —
- Beta (5Y)
- 2.27
- 52-week high
- $36.99
- 52-week low
- $2.82
- Avg volume (3M)
- —
- Shares outstanding
- 13.35M
- Employees
- 5
- Next earnings
- —
About Greenland Mines Ltd
Greenland Mines Ltd operates across two segments: natural resources and cell and gene therapy. Its resources arm is focused on exploring for palladium, gold, and platinum, centered on the exploration and development of the Skaergaard project in Southeast Greenland. On the therapeutics side, the company is developing KLTO-202, a gene therapy targeting the treatment and prevention of amyotrophic lateral sclerosis (ALS), and KLTO-101, aimed at treating or preventing Alzheimer's disease, alongside therapies for Parkinson's and other age-related conditions. Previously known as Klotho Neurosciences, Inc., the company adopted its current name in March 2026. It is headquartered in Charlotte, North Carolina.
- ISIN
- US49876K2024
- Listed since
- Apr 29, 2022
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Acrivon Therapeutics, Inc.NasdaqGM: ACRV | $81.85M | $1.75 | -8.38% |
| Prestige Biologics Co., Ltd.KOSDAQ: A334970 | $81.43M | ₩1,408.00 | -1.81% |
| BIONET Therapeutics Corp.TPEX: 7808 | $81.00M | NT$37.00 | -8.64% |
| Sera Prognostics, Inc.NasdaqGM: SERA | $80.48M | $2.06 | +0.74% |
| GlycoNex IncorporationTPEX: 4168 | $80.23M | NT$22.80 | +1.79% |
| BioPorto A/SCPSE: BIOPOR | $79.36M | Dkr1.04 | -2.80% |
| Nordicus Partners CorporationOTCPK: NORD | $79.33M | $4.08 | +1.77% |
| Brii Biosciences LimitedSEHK: 2137 | $79.11M | HK$0.86 | -3.37% |
Figures last refreshed Oct 11, 2026.